Primary study · included by 1 review

Effectiveness of glutamine for the treatment of radiodermatitis in cancer patients: a meta-analysis of randomized controlled trials.

Chang 2024 · Chang Hsu-Chieh, Huang Wen-Yen, Chen Po-Huang, et al. · Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2024

Included by

The Efficacy and Safety of Nutritional Supplements for Cancer Supportive Care: An Umbrella Review and Hierarchical Evidence Synthesis.

Non-Cochrane · umbrella · 2026 · cited as Chang 2024 · Reference 73; Tables 2-8

Outcome this study informs	Pooled effect	Evidence	Certainty
Radiodermatitis incidence Glutamine or HMB/arginine/glutamine (14 to 30 g/d glutamine) vs Placebo or no treatment	RR 0.90 [0.81, 1.00]	5 studies · 218 participants	Very low
Radiodermatitis severity, grade 2 to 4 Glutamine or HMB/arginine/glutamine (14 to 30 g/d glutamine) vs Placebo or no treatment	RR 0.49 [0.32, 0.76]	5 studies · 218 participants	Moderate

1 including review in total.